New insight into metaphase arrest by cytostatic factor: from establishment to release

Oncogene. 2007 Feb 26;26(9):1286-9. doi: 10.1038/sj.onc.1210203.

Abstract

Since the discovery of cytostatic factor (CSF) 35 years ago, significant progress has been made in identifying molecular components of CSF activity and the mechanism of CSF-induced metaphase II arrest (CSF arrest). This short review focuses on recent discoveries in the field and discusses the implication of these results for a general picture of CSF establishment and release. One recent focus is on the cyclin E/Cdk2 pathway. The discovery of a downstream target for cyclin E/Cdk2, the spindle checkpoint protein Mps1, provides insight into how cyclin E/Cdk2 contributes to CSF arrest. The anaphase promoting complex/cyclosome (APC/C) inhibitor Emi2 is another recent focus of work in the field. It is now clear that not only is degradation of Emi2 critical for CSF release, but its abrupt accumulation during meiosis II (M II) is also required for the establishment of CSF arrest. Thus, by discrete pathways of APC/C inhibition operative during CSF arrest, the stability of cell cycle arrest in the egg appears to be reinforced by multiple mechanisms.

Publication types

  • Review

MeSH terms

  • Calcium / physiology
  • Humans
  • Metaphase / physiology*
  • Proto-Oncogene Proteins c-mos / antagonists & inhibitors
  • Proto-Oncogene Proteins c-mos / physiology*

Substances

  • Proto-Oncogene Proteins c-mos
  • Calcium